O risk of dying from Covid-19 in Italy reduced by 95% from the seventh week after the administration of the first dose of the vaccine against the disease, showed a study published by the Instituto Superior de Saúde (ISS) and the National Institute of Statistics (Istat) on Thursday (10).
The document explains that vaccination “brought a notable reduction in the risk of death less than two months after receiving the dose”.
Another positive index is that, compared to 2020, there was a drop in percentage terms in contamination by the Sars-CoV-2 coronavirus in the very elderly population, that is, over 80 years old, and a drop in the average age of people who contracted the virus. illness.
“This is a sign of how vaccination campaign, the recommendations and prevention put into practice had positive success in reducing the transmission of the disease in the elderly population, but it is also a consequence of the diagnostic capacity and case monitoring activities”, the report further states.
ISS-Istat also reports that there was excellent population adherence to the campaign, with 95% of those vaccinated returning to take the second dose, when necessary, and that “after seven weeks, an 80% reduction in risk is still estimated of infection and 90% of the risk of hospitalization”.
The data was recorded until June 7, when 38.178.684 doses of vaccines from Pfizer/BioNTech, Moderna, Oxford/AstraZeneca and Janssen had been administered in the country.
Of these, 13.028.350 people completed the immunization cycle (two doses or a single dose of Janssen), which represented 24,01% of the population over 12 years of age.
Italy has been accelerating the rollout of vaccines since the beginning of May, with an average of 3,4 million doses administered in the last five weeks. (Loop)
FOLLOW-US
